Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infection as a Cause of Chronic Subdural Hematoma
NCT07556991Phase 3Recruiting
- Sponsor
- Universität Rostock
- Start
- Sep 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amoxicillin + clavulanate in chronic subdural hematoma (CSDH), sponsored by Universität Rostock. Started Sep 2024; status: recruiting.
02
Drugs
amoxicillin + clavulanate
03
Conditions
chronic subdural hematoma (CSDH)
Beyond the preview
Go deeper on NCT07556991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07556991.